Merck KGaA Company Insiders
| MKKGY Stock | USD 29.53 0.45 1.55% |
Merck KGaA employs about 63.7 K people. The company is managed by 10 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 6372.3 employees per reported executive. Break down of Merck KGaA's management performance can provide insight into the company performance.
| Matthias Heinzel Insider CEO Board |
| Peter Guenter Insider CEO Board |
Merck |
Merck KGaA Management Team Effectiveness
The company has return on total asset (ROA) of 0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. Merck KGaA's management efficiency ratios could be used to measure how well Merck KGaA manages its routine affairs as well as how well it operates its assets and liabilities.Merck KGaA Workforce Comparison
Merck KGaA ADR is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 512,464. Merck KGaA retains roughly 63,723 in number of employees claiming about 12% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. Merck KGaA ADR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Merck KGaA ADR Price Series Summation is a cross summation of Merck KGaA price series and its benchmark/peer.
Merck KGaA Notable Stakeholders
A Merck KGaA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck KGaA often face trade-offs trying to please all of them. Merck KGaA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck KGaA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marcus Kuhnert | Member of the Executive Board, CFO | Profile | |
| Matthias Heinzel | CEO Board | Profile | |
| Peter Guenter | CEO Board | Profile | |
| Barbara Weiland | Chief Officer | Profile | |
| Dirk Toepfer | Chief Officer | Profile | |
| Gerhard Schmitz | Head Accounting | Profile | |
| Belen MD | Chair CEO | Profile | |
| Kai Beckmann | Chief Administrative Officer, Member of the Executive Board | Profile | |
| Constantin Fest | Head of Investor Relations | Profile | |
| Friederike Rotsch | Group Compliance | Profile |
About Merck KGaA Management Performance
The success or failure of an entity such as Merck KGaA ADR often depends on how effective the management is. Merck KGaA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 62770 people.
Please note, the imprecision that can be found in Merck KGaA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck KGaA ADR. Check Merck KGaA's Beneish M Score to see the likelihood of Merck KGaA's management manipulating its earnings.
Merck KGaA Workforce Analysis
Traditionally, organizations such as Merck KGaA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck KGaA within its industry.Merck KGaA Manpower Efficiency
Return on Merck KGaA Manpower
| Revenue Per Employee | 308.9K | |
| Revenue Per Executive | 2B | |
| Net Income Per Employee | 47.9K | |
| Net Income Per Executive | 305.5M |
Additional Tools for Merck Pink Sheet Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.